{"id":"NCT02201953","sponsor":"Gilead Sciences","briefTitle":"Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection","officialTitle":"A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Subjects With Chronic Genotype 3 HCV Infection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-07","primaryCompletion":"2015-09","completion":"2015-12","firstPosted":"2014-07-28","resultsPosted":"2016-10-26","lastUpdate":"2018-11-16"},"enrollment":558,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis C Virus Infection"],"interventions":[{"type":"DRUG","name":"SOF/VEL","otherNames":["Epclusa®","GS-7977/GS-5816"]},{"type":"DRUG","name":"SOF","otherNames":["Sovaldi®","GS-7977","PSI-7977"]},{"type":"DRUG","name":"RBV","otherNames":[]}],"arms":[{"label":"SOF/VEL 12 Weeks","type":"EXPERIMENTAL"},{"label":"SOF+RBV 24 Weeks","type":"EXPERIMENTAL"}],"summary":"The primary objectives of this study are to compare the efficacy of treatment with sofosbuvir/velpatasvir (SOF/VEL) fixed-dose combination (FDC) for 12 weeks with that of sofosbuvir (SOF) + ribavirin (RBV) for 24 weeks and to evaluate the safety and tolerability of each treatment regimen in participants with chronic genotype 3 hepatitis C virus (HCV) infection.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response (SVR) 12 Weeks After Discontinuation of Therapy (SVR12)","timeFrame":"Posttreatment Week 12","effectByArm":[{"arm":"SOF/VEL 12 Weeks","deltaMin":95.3,"sd":null},{"arm":"SOF+RBV 24 Weeks","deltaMin":80.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":76,"countries":["United States","Australia","Canada","France","Germany","Italy","New Zealand","Puerto Rico","United Kingdom"]},"refs":{"pmids":["26575258","36740893","27847279"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":277},"commonTop":["Headache","Fatigue","Insomnia","Nausea","Nasopharyngitis"]}}